Alternatives to Modafinil for Daytime Sleepiness in OSA

Primary Treatment Options

The American College of Physicians recommends CPAP therapy as the first-line treatment for patients with excessive daytime sleepiness associated with OSA, showing improvement in sleep quality and daytime sleepiness 1, 2, 3
Weight loss is strongly encouraged for all overweight and obese patients with OSA, as it can improve breathing patterns, sleep quality, and daytime sleepiness, according to the American College of Physicians 1, 2, 3
Mandibular advancement devices (MADs) are recommended as an alternative to CPAP for patients who cannot tolerate CPAP or prefer these devices, as suggested by the European Respiratory Society 1, 4, 3

The European Respiratory Society recommends mandibular advancement devices to reduce sleep apneas and subjective daytime sleepiness, improving quality of life compared to control treatments 4, 5, 6
Positional therapy may help in younger, less obese patients with mild OSA and position-dependent symptoms, according to the European Respiratory Society 4, 7, 6
Hypoglossal nerve stimulation can be considered in selected adult patients seeking alternative treatments, as suggested by the Pulmonology society 6
Myofunctional therapy may be considered in specific cases, though it's a conditional recommendation, according to the Pulmonology society 6

The American Academy of Sleep Medicine recommends modafinil or armodafinil only for treating residual excessive daytime sleepiness in patients who are already using effective CPAP therapy and have no other identifiable causes for their sleepiness 8, 9
Clinicians must rule out suboptimal CPAP adherence, ill-fitting masks, insufficient sleep, poor sleep hygiene, other sleep disorders, and depression before considering modafinil, as suggested by the American Academy of Sleep Medicine 8
Methylphenidate or dextroamphetamine may be options for refractory daytime sedation, according to the National Comprehensive Cancer Network 9
Caffeine is another option for daytime sedation, with the last dose given no later than 4:00 pm, as recommended by the National Comprehensive Cancer Network 9

The European Respiratory Society recommends tonsillectomy for OSA treatment in adults with tonsillar hypertrophy 4
Maxillofacial surgery or otolaryngologic surgery may be options for specific cases, as suggested by the Pulmonology society 6
Surgical treatments should not be used as initial treatment due to associated risks and serious adverse effects, according to the American College of Physicians 1, 2